Swiss CRO PSI reaches into South Africa

Psi, a global CRO out of Switzerland, has expanded into South Africa, touting the nation's diversity and regulatory environment as ideal for patient recruitment and drug development in oncology, CNS, urology, diabetes and other therapeutic areas. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.